Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-ge... Invion Limited, a clinical-stage life sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia. The company develops IVX-PDT, a photosensitising agent to treat a range of cancers, such as skin, prostate, ano-genital, glioblastoma multiforme, lung, and ovarian cancers; and human papilloma virus. It is also involved in the development of INV043, which is in Phase II clinical trial for the treatment of patients with prostate cancer; and in Phase I/II clinical trial to treat non-melanoma skin cancer, as well as for the treatment of oesophageal cancer. The company has collaborations with Hudson Institute of Medical Research, Peter MacCallum Cancer Centre, Dr. I&B Co., Ltd., and Hanlim Pharm Co., Ltd. Invion Limited was incorporated in 2000 and is headquartered in Melbourne, Australia. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.002 | -4 | 0.05 | 0.05 | 0.044 | 99320 | 0.04588056 | DE |
| 4 | -0.01 | -17.2413793103 | 0.058 | 0.072 | 0.044 | 328416 | 0.05265389 | DE |
| 12 | -0.029 | -37.6623376623 | 0.077 | 0.08 | 0.044 | 189110 | 0.05737631 | DE |
| 26 | -0.051 | -51.5151515152 | 0.099 | 0.11 | 0.044 | 151135 | 0.06939051 | DE |
| 52 | -0.067 | -58.2608695652 | 0.115 | 0.2 | 0.044 | 130584 | 0.08871283 | DE |
| 156 | 0.042 | 700 | 0.006 | 0.43 | 0.002 | 1080823 | 0.01035076 | DE |
| 260 | 0.031 | 182.352941176 | 0.017 | 0.43 | 0.002 | 2755623 | 0.01802119 | DE |
wingnutt01
11分前
Duke Knockem
11分前
berta
12分前
zab
12分前
B402
18分前
Madguppy
20分前
joe_techi
22分前
PRmaniac
22分前
alwayswatching1
24分前
jog49
25分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。